RATE AND DETERMINANTS OF VIROLOGIC FAILURE IN HIV-INFECTED YOUTH RECEIVING FIRST-LINE EMTRICITABINE/ TENOFOVIR DISOPROXIL FUMARATE/ EFAVIRENZ (ATRIPLA®) COMPARED TO OTHER ANTIRETROVIRAL DRUG REGIMENS

Ryan Van Ramshorst, Cosmina Gingaras, Claudia A. Kozinetz, Elizabeth Montgomery Collins, Ingrid Hansen, Heidi Schwarzwald

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'RATE AND DETERMINANTS OF VIROLOGIC FAILURE IN HIV-INFECTED YOUTH RECEIVING FIRST-LINE EMTRICITABINE/ TENOFOVIR DISOPROXIL FUMARATE/ EFAVIRENZ (ATRIPLA®) COMPARED TO OTHER ANTIRETROVIRAL DRUG REGIMENS'. Together they form a unique fingerprint.

Nursing and Health Professions

Immunology and Microbiology